Cancer Care Specialists of Illinois

Decatur, Illinois 62526-5858

5 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Cachexia, Cancer of the Prostate, Diffuse Large B Cell Lymphoma, Extensive Stage Small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Hormone Sensitive Prostate Cancer, Marginal Zone Lymphoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Metastatic Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Prostate Cancer

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue — Recruiting now
• A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) — Recruiting now
• GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. — Stopped early
• Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation — Completed